Ultragenyx Pharmaceutical RARE
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$200.9K (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 41.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 16.12% to 23.96% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Madison Avenue Partners, LP | Hedge Fund | 2026/Q3 | +6,307,798 | 6.2% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,628,970 | 8.3% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,379,312 | 7.4% |
| GW&K Investment Management, LLC | Mutual Fund | 2026/Q3 | +826,666 | 2.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +778,577 | 11.3% |
| Scout Investments, Inc. | Mutual Fund | 2026/Q3 | +743,419 | 0.7% |
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +742,295 | 0.8% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +695,674 | 0.7% |
| Citigroup Inc. | Public Company | 2026/Q3 | +467,239 | 0.8% |
| Barclays PLC | Public Company | 2026/Q3 | +455,599 | 0.6% |
| RTW Investments, LP | Hedge Fund | 2026/Q3 | +4,148,100 | 7.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,354,678 | 10.8% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +1,972,711 | 6.4% |
| Jacobs Levy Equity Management Inc | Mutual Fund | 2026/Q3 | +1,508,648 | 2.9% |
| MPM BioImpact LLC | VC/PE Fund | 2026/Q3 | +1,418,215 | 1.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -7,066 | $15.27 | 13,026 |
| 14 Sep 2026 | Theodore Huizenga | Senior VP, Corporate Controller & Principal Accounting Officer | Open Market Disposition | -1,283 | $13.57 | 30,856 |
| 2 Sep 2026 | Theodore Huizenga | Senior VP, Corporate Controller & Principal Accounting Officer | Open Market Disposition | -161 | $13.99 | 31,963 |
| 2 Aug 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -4,696 | $24.92 | 96,295 |
| 2 Aug 2026 | Karah Parschauer | Chief Legal Officer & Executive VP of Corporate Affairs | Open Market Disposition | -1,900 | $24.92 | 38,397 |
| 30 Jun 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -4,698 | $33.13 | 4,695 |
| 14 Jun 2026 | Corazon Sanders | Independent Director | Open Market Disposition | -2,000 | $25.05 | 13,344 |
| 14 Jun 2026 | Karah Parschauer | Chief Legal Officer & Executive VP of Corporate Affairs | Open Market Disposition | -1,899 | $24.62 | 40,297 |
| 31 May 2026 | Howard Horn | Executive VP of Corporate Strategy & CFO | Open Market Disposition | -4,653 | $23.77 | 9,392 |
| 17 May 2026 | Shehnaaz Suliman | Independent Director | Open Market Disposition | -5,740 | $25.12 | 20,200 |
| 13 May 2026 | Daniel Welch | Independent Non-Executive Chairperson | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Daniel Welch | Independent Non-Executive Chairperson | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Matthew Fust | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Matthew Fust | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Shehnaaz Suliman | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Shehnaaz Suliman | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Deborah Dunsire | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Deborah Dunsire | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
| 13 May 2026 | Corazon Sanders | Independent Director | Other Acquisition | +7,751 | – | 7,751 |
| 13 May 2026 | Corazon Sanders | Independent Director | Other Derivative Acquisition | +14,058 | $25.80 | 14,058 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 23,624,682 | 24.0% | 8.3 |
| 15 Oct 2026 | 20,145,283 | 20.4% | 5.2 |
| 30 Sep 2026 | 20,349,877 | 20.6% | 3.1 |
| 15 Sep 2026 | 16,571,956 | 16.8% | 2.2 |
| 31 Aug 2026 | 17,144,354 | 17.4% | 8.0 |
| 14 Aug 2026 | 15,887,767 | 16.1% | 7.8 |
No comments yet — be the first to weigh in on RARE.
Sign in to join the discussion.